The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Dr. N Lehners | ASH 2017 | Key highlights: Myeloma - pathophysiology & pre-clinical studies

Jan 5, 2018

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA

Dr. Nicola Lehners
German Cancer Research Center, Heidelberg, DE

Interview topic: Key highlights of the session: Myeloma: pathophysiology and pre-clinical studies, excluding therapy - emerging new targets and mechanisms of resistance

Key highlights: Myeloma - pathophysiology & pre-clinical studies